Module
Treatment for Hepatitis C Nonresponders and Relapsers
Source: Hepatitis Annual Update 2005
Treatment for Hepatitis C Nonresponders and Relapsers
Program Director: Patrick J. Lynch, MD
|
Learning Objectives
Upon completion of this activity, participants should be able to:
Describe factors associated with hepatitis C nonresponse and relapse Review data supporting hepatitis C maintenance therapy, including ongoing studies Discuss the role of novel agents, including replication inhibitors, in the treatment of hepatitis C nonresponders and relapsers
Content includes:
- The Basis for Nonresponse: Overview
- Viral Factors
- Host Factors
- Choice of Therapy
- Generic Factors
- Factors Associated With Response in Nonresponders
- How Are These Factors Being Addressed?: Viral Kinetic Studies
- Varying Treatment Regimens and Improving Compliance
- What Is the Role of Maintenance Therapy?
- Where Are the New Agents Currently?
- The Future
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.
Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|
|